Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Chongsheng Qian"'
Autor:
Lihong Zhang, Haifei Yang, Chongsheng Qian, Jihao Zhou, Qian Zhu, Yibin Jiang, Shuo Liu, Xiaochen Chen, Ting Xu, Changju Qu, Caixia Li, Zhengming Jin, Jianhong Chu, Xinyou Zhang, Depei Wu, Haiwen Huang
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 404-411 (2022)
Objectives The aim of this retrospective study was to evaluate the safety and efficacy of SEAM regimen followed by auto-SCT in lymphoma.Patients and methods We retrospectively reviewed the records of patients with lymphoma who underwent auto-SCT with
Externí odkaz:
https://doaj.org/article/12a9e5b2c6b54c508988f4a6d827f7ac
Autor:
Zheng LI, Hao Zhang, Yanyan LI, Lulu Chen, Haiping Dai, Haixia Zhou, Mingzhu Xu, Tongtong Zhang, Chongsheng Qian, Wenjie Gong, Qiaocheng Qiu, Aining Sun, Depei Wu, Shengli Xue
Publikováno v:
HemaSphere, Vol 7, p e204697f (2023)
Externí odkaz:
https://doaj.org/article/518dc994715d42fa895962ceb0a82f54
Autor:
Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Wei Cui, Baoquan Song, Jia Yin, Zheng Li, Xiaming Zhu, Changju Qu, Tianhui Liu, Wenhong Shen, Mingqing Zhu, Lei Yu, Depei Wu, Xiaowen Tang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Abstract Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are
Externí odkaz:
https://doaj.org/article/cc14e2093e194871ac3d015e17b11a2e
Autor:
Chongsheng Qian, Arnaud Campidelli, Yingying Wang, Huili Cai, Véronique Venard, Hélène Jeulin, Jean Hugues Dalle, Cécile Pochon, Maud D’aveni, Benedicte Bruno, Catherine Paillard, Stéphane Vigouroux, Charlotte Jubert, Patrice Ceballos, Aude Marie-Cardine, Claire Galambrun, Clément Cholle, Isabelle Clerc Urmes, Nadine Petitpain, Marcelo De Carvalho Bittencourt, Véronique Decot, Loïc Reppel, Alexandra Salmon, Laurence Clement, Danièle Bensoussan
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-14 (2017)
Abstract Background Allogeneic hematopoietic stem cell transplantation (HSCT), the most widely used potentially curable cellular immunotherapeutic approach in the treatment of hematological malignancies, is limited by life-threatening complications:
Externí odkaz:
https://doaj.org/article/72d95c9f5bc14cc98e842c840600db25
Publikováno v:
Annals of Hematology. 102:973-975
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fd95f799a0899635c419b5c6e2d616a
https://doi.org/10.1007/s00277-023-05110-y
https://doi.org/10.1007/s00277-023-05110-y
Autor:
Meng Cheng, Chongsheng Qian, Haixia Zhou, Yaqin Cao, Mingzhu Xu, Tongtong Zhang, Shengli Xue, Aining Sun
Publikováno v:
Transplantation Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3433c65cd99dcb488295e0900febc70d
https://doi.org/10.1016/j.transproceed.2023.04.027
https://doi.org/10.1016/j.transproceed.2023.04.027
Autor:
Yanyan Li, Haixia Zhou, Chaoling Wan, Mingzhu Xu, Chongsheng Qian, Tongtong Zhang, Haiping Dai, AiNing Sun, Depei Wu, Shengli Xue
Publikováno v:
Blood. 140:3212-3213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92747e044a140245464db89038217a21
https://doi.org/10.1182/blood-2022-168054
https://doi.org/10.1182/blood-2022-168054
Autor:
Chongsheng Qian, Mingzhu Xu, Xiao Ma, Shengli Xue, Aining Sun, Depei Wu, Jin Wang, Lian Bai, Song-Bai Liu, Ting-Jing Wang, Haixia Zhou
Publikováno v:
Bone Marrow Transplantation. 56:1003-1005
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d10ce981597acf8aad048743a705bc1
https://doi.org/10.1038/s41409-020-01130-8
https://doi.org/10.1038/s41409-020-01130-8
Autor:
Changju Qu, Xiaming Zhu, Zheng Li, Wei Cui, Qingya Cui, Haiping Dai, Lei Yu, Chongsheng Qian, Liqing Kang, Nan Xu, Jia Yin, Baoquan Song, Wenhong Shen, Ming-Qing Zhu, Depei Wu, Xiaowen Tang, Tianhui Liu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-5 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321de5e0339b3ae104fa8e8044b94a26
https://doi.org/10.1186/s13045-021-01092-4
https://doi.org/10.1186/s13045-021-01092-4
Autor:
Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Wei Cui, Baoquan Song, Jia Yin, Zheng Li, Xiaming Zhu, Lei Yu, Depei Wu, Xiaowen Tang
Publikováno v:
SSRN Electronic Journal.
Background: There are few effective therapies for relapsed acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which has a poor prognosis. Few successful CAR-T cell therapies in AML have been reported. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4cb2a398c08925158fa234e76167c8
https://doi.org/10.2139/ssrn.3709873
https://doi.org/10.2139/ssrn.3709873